Saturday 23 June 2018
Sun Pharma

Sun pharma eyes Swedish firm for $5bn

India's Sun Pharmaceutical Industries is in talks to buy Sweden's Meda AB for between $5 billion and $6 billion to boost its generics business in developed markets, two sources with direct knowledge of the process said. Me


Merck, Sun Pharma set up generics JV

Helathcare leader Merck has joined hands with India's Sun Pharmaceutical Industries to develop, manufacture and commercialise new combinations and formulations of innovative, branded generics in the emerging markets. The tieu

 1 2 3 4 5 >  Last ›

calendarCalendar of Events